Literature DB >> 538064

Experiments with a reported anorexigenic tripeptide: pyro-Glu-His-Gly-OH.

D M Nance, D H Coy, A J Kastin.   

Abstract

A newly described tripeptide, pyro-Glu-His-Gly-OH, which was reported to produce profound and long-term anorexia and weight loss in female mice, was initially tested in female rats. After total dose of either 8, 16, or 32 microgram SC of the peptide, administered across an eight day interval, there was no detectable effect on food intake, body weight, or estrous cycles of female rats. In a second study, we attempted to verify the anorexigenic potency of this peptide in mice. Total doses of 3.4 and 6.8 microgram, injected across a 20 day period, had no effect on the food intake or body weight of S/W albino female mice. Thus, the anorexigenic potency of pyro-Glu-His-Gly-OH has yet to be established.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 538064     DOI: 10.1016/0091-3057(79)90273-9

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  4 in total

Review 1.  Satietin; a 50,000 dalton glycoprotein in human serum with potent, long-lasting and selective anorectic activity.

Authors:  J Knoll
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

2.  Peptides and the control of meal size.

Authors:  S C Woods; D B West; Leslie J Stein; L D McKay; Elizabeth C Lotter; Stephanie G Porte; Nancy J Kenney; D Porte
Journal:  Diabetologia       Date:  1981-03       Impact factor: 10.122

3.  Urinary peptide levels in women with eating disorders. A pilot study.

Authors:  M Hellzén; J O Larsson; K L Reichelt; P A Rydelius
Journal:  Eat Weight Disord       Date:  2003-03       Impact factor: 4.652

4.  Effects of anorexigenic peptide on gastric and pancreatic secretion.

Authors:  D Coy; J Jaworek; S J Konturek; N Kwiecień; T Radecki; A V Schally; J Tasler
Journal:  J Physiol       Date:  1981-05       Impact factor: 5.182

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.